NFKB1 and major depressive disorder: Inhibition of key inflammatory pathways such as P2X7R/NLRP3 and NF-κB signaling pathways, regulation of hypothalamic–pituitary–adrenal axis (HPA axis) function, and tryptophan metabolism improved depression-like behavior in rodent models.